Afuco™ Anti-Human HLA-DR10 ADCC Therapeutic Antibody (LYM-1), ADCC Enhanced
Anti-HLA-DR10 ADCC Enhanced Antibody (LYM-1) is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies Lym-1 reactive with the cell surface of B-lymphocytes and derived tumors, have indicated significant anti-tumour activity against lymphoma cell lines.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-347CL |
| Pricing | Inquiry |
| Host | Mouse |
| Target | HLA-DR10 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |